Literature DB >> 7845686

Deregulation of genes encoding microfilament-associated proteins during Fos-induced morphological transformation.

K U Jooss1, R Müller.   

Abstract

The mechanism of Fos-induced transformation is still poorly understood. In the present study, we have asked whether genes whose products play a role in determining cell morphology might become deregulated in the course of Fos-induced transformation. A clear up-regulation in Fos-transformed rat fibroblasts was seen with ezrin, as well as tropomyosin (TM) -3 and -5B, while TM-1 was down-regulated. Significantly, the same genes were deregulated in a very similar, but hormone-inducible way in cells expressing a Fos-estrogen receptor fusion protein. In agreement with these results, Fos-expressing cells showed decreased levels of two TM isoforms of 36 and 38 kDa, and showed an impaired TM network. The significance of these observations is strengthened by the fact that the deregulation of TM expression has been shown to contribute to morphological transformation in other experimental systems. Deregulation of the TM and ezrin genes preceeds the induction of morphological transformation suggesting that this deregulation is not merely a consequence of transformation. On the other hand, deregulation follows the induction of direct Fos target genes. We therefore propose that a cascade of regulatory events is triggered by Fos oncoproteins which eventually leads to the deregulation of genes encoding cytoskeleton-associated proteins.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7845686

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  17 in total

1.  Ezrin function is required for ROCK-mediated fibroblast transformation by the Net and Dbl oncogenes.

Authors:  C Tran Quang; A Gautreau; M Arpin; R Treisman
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

2.  Synaptogenesis and Fos expression in the motor cortex of the adult rat after motor skill learning.

Authors:  J A Kleim; E Lussnig; E R Schwarz; T A Comery; W T Greenough
Journal:  J Neurosci       Date:  1996-07-15       Impact factor: 6.167

Review 3.  Emerging roles of ATF2 and the dynamic AP1 network in cancer.

Authors:  Pablo Lopez-Bergami; Eric Lau; Ze'ev Ronai
Journal:  Nat Rev Cancer       Date:  2010-01       Impact factor: 60.716

4.  Autocrine growth and anchorage independence: two complementing Jun-controlled genetic programs of cellular transformation.

Authors:  H van Dam; S Huguier; K Kooistra; J Baguet; E Vial; A J van der Eb; P Herrlich; P Angel; M Castellazzi
Journal:  Genes Dev       Date:  1998-04-15       Impact factor: 11.361

5.  Ezrin immunoreactivity is associated with increasing malignancy of astrocytic tumors but is absent in oligodendrogliomas.

Authors:  K D Geiger; P Stoldt; W Schlote; A Derouiche
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

6.  Specific activation in jun-transformed avian fibroblasts of a gene (bkj) related to the avian beta-keratin gene family.

Authors:  M Hartl; K Bister
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

7.  AP-1-mediated invasion requires increased expression of the hyaluronan receptor CD44.

Authors:  R F Lamb; R F Hennigan; K Turnbull; K D Katsanakis; E D MacKenzie; G D Birnie; B W Ozanne
Journal:  Mol Cell Biol       Date:  1997-02       Impact factor: 4.272

8.  Reciprocal regulation by estradiol 17-beta of ezrin and cadherin-catenin complexes in pituitary GH3 cells.

Authors:  Perry M Smith; C Amanda Heinrich; Stacey Pappas; John J Peluso; Ann Cowan; Bruce A White
Journal:  Endocrine       Date:  2002-04       Impact factor: 3.633

9.  Ezrin self-association involves binding of an N-terminal domain to a normally masked C-terminal domain that includes the F-actin binding site.

Authors:  R Gary; A Bretscher
Journal:  Mol Biol Cell       Date:  1995-08       Impact factor: 4.138

10.  Ezrin expression in stromal cells of capillary hemangioblastoma. An immunohistochemical survey of brain tumors.

Authors:  T Böhling; O Turunen; J Jääskeläinen; O Carpen; M Sainio; T Wahlström; A Vaheri; M Haltia
Journal:  Am J Pathol       Date:  1996-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.